You have 9 free searches left this month | for more free features.

Abscopal

Showing 1 - 25 of 166

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors, Secondary Malignant Tumor Trial (SBRT + LDRT, SBRT alone)

Not yet recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • SBRT alone
  • (no location specified)
Nov 15, 2022

Tumors, Secondary Malignant Tumor Trial in Seoul (SBRT + LDRT)

Recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • Seoul, Korea, Republic of
  • +1 more
Feb 16, 2023

Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)

Recruiting
  • Thymoma
  • Radiotherapy Combined with GM-CSF
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 2, 2022

Radiation Effects on Bone

Enrolling by invitation
  • Soft Tissue Sarcoma Adult
  • Control Group
  • +3 more
  • Syracuse, New York
    SUNY Upstate Medical University
Oct 31, 2022

Bystander Effect, Abscopal Effect, Unresectable Malignant Solid Tumor Trial in Klagenfurt (SBRT-PATHY (SBRT-based PArtial Tumor

Recruiting
  • Bystander Effect
  • +3 more
  • SBRT-PATHY (SBRT-based PArtial Tumor irradiation targeting HYpoxic segment)
  • Klagenfurt, Kaernten, Austria
    KABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Apr 6, 2022

Non-Small-Cell Lung Cancer Stage IV Trial in Chongqing (Bevacizumab, Toripalimab, SBRT)

Recruiting
  • Non-Small-Cell Lung Cancer Stage IV
  • Chongqing, Chongqing, China
    Xinqiao Hospital of Chongqing
May 13, 2021

Solid Tumor, Lymphoma Trial in Beijing (Manganese Chloride, Radiotherapy, Chemo-immunotherapy)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Manganese Chloride
  • +2 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
May 4, 2021

Melanoma Trial in France (Nivolumab + Ipilimumab, Combined treatment schema)

Terminated
  • Melanoma
  • Nivolumab + Ipilimumab
  • Combined treatment schema
  • Bordeaux, France
  • +5 more
Dec 3, 2020

Thymic Epithelial Tumor Trial in Shanghai (rhGM-CSF,Peginterferon alfa-b2,radiation)

Not yet recruiting
  • Thymic Epithelial Tumor
  • rhGM-CSF,Peginterferon alfa-b2,radiation
  • Shanghai, Shanghai, China
    Fudan University shanghai cancer center
Aug 16, 2020

Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Liver, Metastatic Malignant Tumor in the Lung Trial in Houston

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Hafnium Oxide-containing Nanoparticles NBTXR3
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Head Neck Cancer Trial in France (Systemic treatment +

Withdrawn
  • Metastatic Breast Cancer
  • +2 more
  • Systemic treatment + Stereotactic Body Radio-Therapy (SBRT)
  • Systemic treatment
  • Albi, France
  • +5 more
Jan 28, 2020

Colorectal Cancer, Metastatic Colorectal Cancer, Thymalfasin Trial (Radiation therapy, Thymalfasin)

Withdrawn
  • Colorectal Cancer
  • +2 more
  • (no location specified)
Jun 18, 2019

Metastatic Colorectal Cancer, pMMR, MSS Trial in France (Atezolizumab, Therasphere, XELOX)

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Amiens, France
  • +18 more
Mar 23, 2022

Cancer Trial in Wiener Neustadt (Particle radiotherapy, Magnetic resonance imaging, Computertomography)

Recruiting
  • Cancer
  • Particle radiotherapy
  • +5 more
  • Wiener Neustadt, Niederösterreich, Austria
    EBG MedAustron GmbH
Dec 1, 2022

Metastatic Pancreatic Cancer Trial in Bern, Basel, Zürich (Nivolumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Bern, BE, Switzerland
  • +2 more
Nov 15, 2022

Small Cell Lung Cancer, Radiotherapy, Thymalfasin Trial (Radiotherapy, Thymalfasin)

Withdrawn
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Mar 19, 2019

NSCLC, Metastatic NSCLC, Radiotherapy Trial (Radiotherapy, Thymalfasin)

Withdrawn
  • Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Mar 23, 2019

Immunotherapy And Palliative Radiotherapy Combined In Advanced

Active, not recruiting
  • Palliative
  • +3 more
  • Palliative Radiation Therapy
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Oct 1, 2021

Pancreas Cancer Trial (Nivolumab, Irreversible electroporation (IRE))

Not yet recruiting
  • Pancreas Cancer
  • (no location specified)
Jun 27, 2022

Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

Recruiting
  • Colorectal Liver Metastases
  • Radiation: High- and Low-dose radiotherapy
  • PD-1 Inhibitors
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2023

Metastatic Malignant Solid Tumor Trial in Duarte (Biospecimen Collection, Computed Tomography, Stereotactic Body Radiation

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Feb 15, 2023

Breast Carcinoma, Metastatic Breast Cancer, Invasive Breast Cancer Trial in Obninsk (Device: Radiation: Diffusing Alpha

Recruiting
  • Breast Carcinoma
  • +3 more
  • Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
  • Obninsk, Kaluga Region, Russian Federation
    A. Tsyb Medical Radiological Research Center
Feb 16, 2022

Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • +2 more
  • Marlborough, Massachusetts
    Phio Pharmaceuticals Corp.
Aug 25, 2023

Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 15, 2022